Amrutanjan Health Care Ltd-$
Financial Results - Machine Readable Format
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 13 May 2026, 12:04 PM IST · BSE ID: 56dc4c8e-b368-4e91-9ed4-e27885653395
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported its full-year financial results and proposed a dividend of Rs. 2.90 per share.
🤖 AI Summary
- Board approved audited financial results for the quarter and year ended March 31, 2026.
- Recommended Final Dividend of Rs. 2.90 per equity share for financial year 2025-26.
- Approved appointment of Mr. Ramaswami Krishnan as Non-Executive Independent Director from May 8, 2026.
- Approved re-appointment of Mr. Muralidharan Swayambunathan as Non-Executive Independent Director from June 29, 2026.
- Approved rolling out of revised Second Phase “ESOP 2” of Employees Stock Option Scheme 2020.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from operations (Year ended March 31, 2026)
INR Lakhs 50,255.27
11.23%
Revenue from operations (Year ended March 31, 2025)
INR Lakhs 45,181.63
Profit after tax (Year ended March 31, 2026)
INR Lakhs 5,791.78
13.93%
Profit after tax (Year ended March 31, 2025)
INR Lakhs 5,083.47
Final Dividend per equity share (FY 2025-26)
Rs. 2.90
🏢 How This Affects the Company
The financial results provide a detailed overview of the company's performance for the fiscal year, with Revenue from operations at INR Lakhs 50,255.27 for FY26. The recommended dividend of Rs. 2.90 per equity share will impact distributable profits and cash reserves upon shareholder approval.
The appointment and re-appointment of Independent Directors will maintain board governance and oversight. The rolling out of the ESOP 2 scheme provides a mechanism for employee participation and retention.
The Auditor’s Report of Annual Financial Results is with an unmodified opinion, indicating no significant audit qualifications, which mitigates financial reporting risk.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will need to approve the recommended final dividend and the appointments/re-appointments of Independent Directors at the Annual General Meeting or through postal ballot.
👤
Who Is Affected
All shareholders owning shares on the record date, once announced, will be eligible for the Rs. 2.90 per equity share dividend. Shareholders will vote on board changes and ESOP rollout.
🔍
Management Signal
The dividend recommendation signals management's intent to distribute profits. Board appointments and ESOP rollout indicate focus on governance and employee incentives.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Annual General Meeting (AGM) date — monitor for dividend approval and director confirmations.
Dividend payment date — verify payment to eligible shareholders within 30 days of AGM.
Postal ballot results — observe approval for director appointments/re-appointments.
LOW RISK
Auditor's report is unmodified, indicating no significant financial reporting concerns.
💡 Investor Takeaway
Amrutanjan Health Care reported FY26 Revenue from operations of INR Lakhs 50,255.27, up from INR Lakhs 45,181.63 YoY. Profit after tax for FY26 was INR Lakhs 5,791.78, up from INR Lakhs 5,083.47 YoY. A final dividend of Rs. 2.90 per equity share was recommended.
⚖️ Strengths & Concerns
✅ Positives
- Revenue from operations increased to INR Lakhs 50,255.27 for the year ended March 31, 2026, compared to INR Lakhs 45,181.63 in prior year.
- Profit after tax for the year ended March 31, 2026, increased to INR Lakhs 5,791.78, from INR Lakhs 5,083.47 in prior year.
⚠️ Concerns
- Other comprehensive income (net of taxes) for the year ended March 31, 2026, decreased to INR Lakhs (13.84) from INR Lakhs (79.22) in prior year.
- Basic earnings per share decreased in Q4 FY26 to INR 5.60 from INR 6.73 in Q3 FY26 (unaudited).
📅 Company Track Record
Amrutanjan Health Care Ltd. previously announced a board meeting on April 30, 2026, to consider FY26 audited results and dividend on May 8, 2026, aligning with the current filing.
Based on publicly available historical data. For context only.